Results

Total Results: 1,314 records

Showing results for "mental disturbance".

61. CHIIPRA 194: Section 6, Table 12 (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-section-6-table-12.pdf
    April 17, 2019 - semicoma, somnolence, stupor, unconsciousness) 780.09 Dizziness and giddiness 780.4 Altered mental

62. CHIIPRA 194: Section 6, Table 12 (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-section-6-table-12.pdf
    April 17, 2019 - semicoma, somnolence, stupor, unconsciousness) 780.09 Dizziness and giddiness 780.4 Altered mental

63. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

64. Psychological and Pharmacological Treatments for Adults with Posttraumatic Stress Disorder (PTSD): A Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/ptsd-adult-treatment-update/research-protocol
    December 01, 2019 - Duration of disturbance symptoms is more than 1 month Criterion F: Duration of disturbance … Duration of disturbance symptoms is more than 1 month None Criterion F: Clinically … significant distress or impairment Duration of disturbance symptoms is more than 1 month … Criterion G: Clinically significant distress or impairment Duration of disturbance symptoms is … Diagnostic and statistical manual of mental disorders. 5th ed.

65. Screening for Suicide Risk in Adolescents, Adults, and Older Adults in Primary Care: Clinical Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/vAKRuLQRL2T7_DHsgFzW_q
    May 13, 2014 - Risk factors for suicide attempt include presence of a mental health disorder; serious adverse childhood … injury, separation from service within the past 12 months, posttraumatic stress disorder, and other mental

66. Module 15: Preparing and Presenting Performance Data (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-15-presenting-data.pdf
    September 01, 2015 - disturbance, difficulty sleeping, suicidal ideation, hallucinations, paranoia Endocrine: denies polyuria … disturbance, difficulty sleeping, suicidal ideation, hallucinations, paranoia Endocrine: denies polyuria … disturbance, difficulty sleeping, suicidal ideation, hallucinations, paranoia Endocrine: denies polyuria … disturbance, difficulty sleeping, suicidal ideation, hallucinations, paranoia Endocrine: denies polyuria … sores, lesions, color change Neurologic: denies syncope Psychiatric: denies depression, anxiety, mental

67. Exhibit 5-8. Measure 8: Plan of care includes at least one public and/or private community service/resource (Wrap-Around Observation Form-2) | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlas-ex58.html
    March 01, 2013 - Measure type: Process Date: 2003 Preventive service / USPSTF: Other–Mental Health * Clinical … an evaluation designed to examine the impact of a system of care for children with serious emotional disturbance … Mental Health Services Research (2003) 5(2):89-96. Epstein, M. H., Nordness, P. … *This is a measure that was originally applied in a mental health setting, but it could be adapted for

68. Exhibit 5-7. Measure 7: Information about area (community) resources is offered by clinician (Wrap-Around Observation Form-2) | Agency for Healthcare Research and Quality
    ce.effectivehealthcare.ahrq.gov/prevention/resources/chronic-care/clinical-community-relationships-measures-atlas/ccrm-atlas-ex57.html
    March 01, 2013 - Measure type: Structural Date: 2003 Preventive service/ USPSTF: Other–Mental Health * Clinical … an evaluation designed to examine the impact of a system of care for children with serious emotional disturbance … Mental Health Services Research (2003) 5(2):89-96. Epstein, M. H., Nordness, P. … *This is a measure that was originally applied in a mental health setting, but it could be adapted for

69. Psychological and Pharmacological Treatments for Adults with Posttraumatic Stress Disorder (PTSD): A Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment-update/research-protocol
    May 24, 2017 - Duration of disturbance symptoms is more than 1 month Criterion F: Duration of disturbance Duration … of disturbance symptoms is more than 1 month None Criterion F: Clinically significant distress … distress or impairment Duration of disturbance symptoms is more than 1 month None Criterion G … Diagnostic and statistical manual of mental disorders. 5th ed. … Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR.

70. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
    December 31, 2017 - • Duration of disturbance symptoms is more than 1 month Criterion F: Duration of disturbance • … Duration of disturbance symptoms is more than 1 month None Criterion F: Clinically significant … significant distress or impairment • Duration of disturbance symptoms is more than 1 month None … Diagnostic and statistical manual of mental disorders. 5th ed. … National Collaborating Centre for Mental Health; 2005.

71. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
    December 31, 2017 - • Duration of disturbance symptoms is more than 1 month Criterion F: Duration of disturbance • … Duration of disturbance symptoms is more than 1 month None Criterion F: Clinically significant … significant distress or impairment • Duration of disturbance symptoms is more than 1 month None … Diagnostic and statistical manual of mental disorders. 5th ed. … National Collaborating Centre for Mental Health; 2005.

72. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

73. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

74. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

75. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

76. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

77. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

78. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - the most expensive, highest in risk, and fastest growing of therapeutic classes for children with mental … Antipsychotics have serious, common side effects, including weight gain, hyperprolactinemia3, and metabolic disturbance … American Academy of Child and Adolescent Psychiatry and the Centers for Education and Research on Mental

79. Spotlight Case [MONTH] 2003 (ppt file)
    psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.161_slideshow.ppt
    October 01, 2007 - cmd=retrieve&db=pubmed&dopt=abstract&list_uids=15913126 Systems and Teamwork The physical and mental … The patient immediately awoke, and the altered mental status and respiratory depression were reversed

80. Recommendation: Eating Disorders in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-eating-disorders-adolescents-adults
    March 15, 2022 - disorder, bulimia nervosa, and anorexia nervosa) are a group of psychiatric conditions defined as a disturbance … weight for age, sex, and developmental trajectory; intense fear of gaining weight or becoming fat; disturbance … Other specific feeding and eating disorder: Eating or feeding disturbance (eg, atypical anorexia nervosa … Diagnostic and Statistical Manual of Mental Disorders . 5th ed. … Risks of all-cause and suicide mortality in mental disorders: a meta-review.